As one of the managed projects of Tianfu Group Health and Medical Division, Beijing Henghe Hospital is established in line with international JCI hospital certification system and the standards of national Class II comprehensive hospitals. It is a private high-end general practice hospital of traditional Chinese and Western medicine. Tianfu Group Health and Medical Division provides the hospital with overall entrusted management services such as strategic planning, engineering design, pre-opening arrangements, informatization construction and management, discipline construction and technical support, supply chain integration, and marketing system. After more than two years of cooperation, Beijing Henghe Hospital is growing in business level and brand awareness, and recently, it has successively reached multiple strategic cooperation with well-known institutions at home and abroad.
Li Guangming, general manager of Tianfu Group Health and Medical Division and director of Beijing Henghe Hospital, attended the signing ceremony and delivered a keynote speech.
On the morning of April 19, "Henghe Obesity Medical Research Center",co-established by Beijing Henghe Hospital of traditional Chinese and Western medicine and Wanfang Medicine of the Technology Division was officially declared formation in Beijing Media Hotel, which is undoubtedly an exploration and innovation in response to the national health strategy.
This is China's first institution integrating "production, learning and research" and specialized in research, treatment and rehabilitation of obesity. The Center will combine the quality medical resources and the advantages of top experts of Henghe Hospital with the academic and data advantages of Wanfang Medicine, and invite relevant experts at home and abroad to do real world studies on hundreds of millions of obese patients in China. By putting practice in the first place, the Center will provide quality and scientific diagnosis and treatment for overweight and obese patients, and on the basis of clinical disease treatment, offer life-time health management services for patients and healthy people.
On April 26, Beijing Henghe Hospital formally signed a strategic cooperation agreement with MORE Health, an American Internet medical institution. Under the premise of resource integration, technology sharing and complementary advantages, the two sides will carry out in-depth cooperation to realize business collaboration and service coordination, and introduce international multidisciplinary consultation services to jointly build an international quality cancer treatment center.
With access to its world's top experts and medical institutions, comprehensive, multidisciplinary and integrative body-mind treatment that combines Chinese and western medicine for cancer patients will be provided. Through close cooperation with international multidisciplinary consultation service platforms, the Hospital will effectively facilitate the close exchanges and cooperation between Chinese and American oncologists in academic thoughts, scientific research achievements and medical technologies.
By building an expert-based comprehensive cancer treatment center, academic exchange center and difficult case consultation center that represent international high standards, Henghe Hospital will, with the concept of whole-course management, provide cancer patients with continuous, interlocking and tightly linked closed-loop services.
Chinese and American experts took photos at Beijing Henghe & MORE Health International Cancer Center
Li Guangming, general manager of Tianfu Group Health and Medical Division and director of Beijing Henghe Hospital, attended the ceremony and delivered a speech.
Chinese and American experts discussed cases together
On the morning of May 17, the first academic seminar since the establishment of Beijing Henghe & MORE Health International Cancer Center was held in Beijing Henghe Hospital, marking the kick-off of academic exchanges between China and America.
The seminar focused on the treatment of hematological diseases. Four MORE Health contracting experts from the University of Chicago:Dr. Wendy Stock, professor of medicine, hematologist and oncologist, Dr. Michael R. Bishop, professor of medicine, and director of Hematopoietic Stem Cell Transplantation Program, Dr. Hongtao Liu, hematologist and oncologist, and Dr. Peter Riedell, hematologist and oncologist were invited to attend the seminar. Professor Shi Xiaodong, chief physician of the Hematology and Oncology Department of the Affiliated Children's Hospital of Capital Institute of Pediatrics, participated in the seminar as a Chinese expert and the chairman of the seminar. In addition, professors from the Peking University People’s Hospital, Tangdu Hospital of the Fourth Military Medical University, the First Affiliated Hospital of China Medical University and other first-class hospitals attended the seminar.
Tianfu Management (Group) Co., Ltd. is an international professional management company, with its business covering 10 major fields including real estate, mining energy, modern service industry, health care, trade, agriculture, technological information, education, investment and finance. With the innovative business model of “Tianfu Finance + Tianfu Management + Tianfu Partners”, the Group provides professional and comprehensive management services for small and medium-sized enterprise clients, focuses on improving clients’ management level, business performance and business value, and helps them build their core competitiveness.
As a professional business division of Tianfu Group providing health care services, the Health and Medical Division will, under the guidance of the development idea of “technology + management guidance with financial support", continue to provide comprehensive services in management, technology, science and technology, finance and human resources for medical institutions and pharmaceutical production and circulation enterprises in health care industry, and help clients better adapt to the development needs of the gradually upgraded health industry.